3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Motor Activity
35
Breast Neoplasms
19
Neoplasms
18
Fatigue
9
Prostatic Neoplasms
4
Lung Neoplasms
4
Hematologic Neoplasms
4
Colorectal Neoplasms
4
Obesity
3
Weight Loss
2
Smoking
2
Sedentary Behavior
2
Postoperative Complications
2
Ovarian Neoplasms
2
Multiple Myeloma
2
Mixed Cancer
2
Lymphedema
2
Frailty
2
Colonic Neoplasms
2
Cardiotoxicity
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urologic Neoplasms
1
Urinary Incontinence
1
Stomach Neoplasms
1
Sarcoma
1
Risk Reduction Behavior
1
Interventions
olaparib
2
pembrolizumab
1
durvalumab
1
camrelizumab
1
apatinib
1
Taxes
1
Surveys and Questionnaires
1
Sentinel Lymph Node Biopsy
1
Robotic Surgical Procedures
1
Radiation Dose Hypofractionation
1
Poly(ADP-ribose) Polymerase Inhibitors
1
Paclitaxel
1
Mindfulness
1
Immune Checkpoint Inhibitors
1
Hysteroscopy
1
Hyperthermic Intraperitoneal Chemotherapy
1
Health
1
Exercise
1
Enhanced Recovery After Surgery
1
Clinical Protocols
1
Carboplatin
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Uterine Neoplasms
×
Exercise
×
Clear all
NCT05561413
2022-10-03
GEMS
University of Ulster
Phase NA
Unknown
40 enrolled